Breaking News

Eurofins Amatsigroup Rebrands to Eurofins CDMO

Provides integrated, end-to-end solutions for pre-clinical and clinical outsourcing services

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

In 2017, Eurofins Scientific, a biopharmaceutical testing firm acquired Amatsigroup SAS to support Eurofins’ extensive drug development platform. Starting July 2, 2019 the commercial brand for Eurofins Amatsigroup is now Eurofins CDMO, falling under the contract development and manufacturing organization (CDMO) umbrella in conjunction with Eurofins’ operations in North America and India. Eurofins CDMO provides integrated, end-to-end solutions for pre-clinical and clinical outsourcing services of...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters